Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
Study NCT ID:
NCT01414205
Status:
COMPLETED
Last Update Posted:
2017-04-17
First Post:
2011-08-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-10
First Submit QC Date:
None
Study First Post Date:
2011-08-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-21
Results First Submit QC Date:
None
Results First Post Date:
2014-04-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-20
Last Update Post Date:
2017-04-17
Last Update Post Date Type:
ACTUAL